Current status of chemotherapy in gynecologic cancer

Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2017

Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Impact of hospital type and treatment on long-term survival among patients with FIGO Stage IIIC epithelial ovarian cancer: follow-up through two recurrences and three treatment lines in search for predictors for survival.

European journal of gynaecological oncology·2016

Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2012

The role of surgery in the second relapse of epithelial ovarian cancer. Selection criteria, morbidity and survival outcome.

European journal of gynaecological oncology·2011

The role of fumarate and itaconate in tumor microenvironment.

Seminars in oncology·2026

Spatiotemporal decoding of the pre-metastatic niche: Multi-omics innovations and clinical horizons.

Seminars in oncology·2026

Integrating patient-reported outcomes into explainable machine learning models for long-term survival prediction in TKI-treated metastatic renal cell carcinoma.

Seminars in oncology·2026

Tumour immunotherapy in solid and hematologic malignancies: Progress, challenges, and a practical framework.

Seminars in oncology·2026

Single-cell sequencing in pan-cancer research: Decoding heterogeneity, tumor microenvironment, and clinical translation.

Seminars in oncology·2026

Atezolizumab, lurbinectedin, tarlatamab, and FOLFIRNOX in a patient with metastatic small cell carcinoma of the anal canal: A case report and review of the literature.

Seminars in oncology·2026

Circular RNA MCM3 recruits USP49 to stabilize PTBP1 and promote cisplatin resistance in cervical squamous cell carcinoma.

Oncogene·2026

Fourier-based chemometric resolution of the FOLFOX regimen through digital filtering with poly-metric sustainability assessment.

Scientific reports·2026

Self-Enhancing Photodynamic / Immunotherapy via a MOF Nanoplatform for Combined STING Activation and Immune Checkpoint Blockade.

Advanced healthcare materials·2026

Comparative effectiveness and safety of carotid endarterectomy, carotid stenting, and optimal medical therapy across symptomatic and asymptomatic carotid stenosis: An updated network meta-analysis of randomized controlled trials.

Cardiovascular revascularization medicine : including molecular interventions·2026

Feasibility and Characterization of Immune-related Pathologic Response Criteria in Renal Cell Carcinoma.

European urology oncology·2026

Digitally enabled patient-centred survivorship care: from hype to implementation-aware impact.

The Lancet. Digital health·2026

Related Experiment Videos

Current status of chemotherapy in gynecologic cancer

Related Concept Videos

Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting.

Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial.

Impact of hospital type and treatment on long-term survival among patients with FIGO Stage IIIC epithelial ovarian cancer: follow-up through two recurrences and three treatment lines in search for predictors for survival.

Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial.

A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer.

The role of surgery in the second relapse of epithelial ovarian cancer. Selection criteria, morbidity and survival outcome.

The role of fumarate and itaconate in tumor microenvironment.

Spatiotemporal decoding of the pre-metastatic niche: Multi-omics innovations and clinical horizons.

Integrating patient-reported outcomes into explainable machine learning models for long-term survival prediction in TKI-treated metastatic renal cell carcinoma.

Tumour immunotherapy in solid and hematologic malignancies: Progress, challenges, and a practical framework.

Single-cell sequencing in pan-cancer research: Decoding heterogeneity, tumor microenvironment, and clinical translation.

Atezolizumab, lurbinectedin, tarlatamab, and FOLFIRNOX in a patient with metastatic small cell carcinoma of the anal canal: A case report and review of the literature.

Circular RNA MCM3 recruits USP49 to stabilize PTBP1 and promote cisplatin resistance in cervical squamous cell carcinoma.

Fourier-based chemometric resolution of the FOLFOX regimen through digital filtering with poly-metric sustainability assessment.

Self-Enhancing Photodynamic / Immunotherapy via a MOF Nanoplatform for Combined STING Activation and Immune Checkpoint Blockade.

Comparative effectiveness and safety of carotid endarterectomy, carotid stenting, and optimal medical therapy across symptomatic and asymptomatic carotid stenosis: An updated network meta-analysis of randomized controlled trials.

Feasibility and Characterization of Immune-related Pathologic Response Criteria in Renal Cell Carcinoma.

Digitally enabled patient-centred survivorship care: from hype to implementation-aware impact.

Related Experiment Videos

Current status of chemotherapy in gynecologic cancer

Related Concept Videos

Related Articles